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Clinical Implications of Topographic Anatomy on the
Ganglion Impar
Chang-Seok Oh, M.D., Ph.D.,* In-Hyuk Chung, M.D., Ph.D.,† Hyun-Ju Ji, B.S.,‡ Duck-Mi Yoon, M.D., Ph.D.§
THE blockade of the ganglion impar, a single ganglion
converged by the caudal ends of the two sympathetic
trunks, has been described to relieve the intractable
perineal pain of sympathetic origin in patients with rec-
tal, anal, colon, bladder, or cervical cancer.1–3 The suc-
cess rate of this method depends on the anatomical
variability of the location of the ganglion,4 but its loca-
tion has been variably reported from the anterior to the
sacrococcygeal joint1–4 or the coccyx,5–8 to the tip of
the coccyx.9 Accordingly, this study was performed to
identify the location of the ganglion impar and to deter-
mine its shape and size and its topographic relation with
the branch of the sacral nerve, in the hope that this might
facilitate a more successful blockade of the ganglion.
Materials and Methods
Fifty sacra and coccyges were removed and dissected
under the surgical microscope (Carl Zeiss, Oberkochen,
Germany). Four to five pairs of sacral ganglia were found
after removing the fascia and fat tissue. The caudal ends of
the two trunks converged into a single ganglion at diverse
sites on the coccyx. Distances of the ganglion impar along
the medial line from the mid sacrococcygeal joint (X) to the
tip of the coccyx (Y) were measured using a digital caliper
(Mitutoyo, Kawasaki, Japan), and the relative index was
calculated as X/X  Y. The distance from the mid sacro-
coccygeal joint to the tip of the coccyx was measured for
the size of the coccyx. The Pearson correlation coefficient
(r) between the size of the coccyx and the distance of the
ganglion impar from the tip of the coccyx was calculated.
Results
The shape of the ganglion was classified as oval (26%),
irregular (20%), triangular (14%), elongated (10%), rect-
angular (8%), and U shaped (8%). In 14% of the samples,
two caudal ends of the sympathetic trunks were con-
nected without forming a recognizable ganglionic shape.
The average long and short diameters of the ganglion
were 2.5 and 1.1 mm for the oval type, 4.2 and 2.5 mm
for the irregular type, 1.9 and 1.3 mm for the triangular
type, 1.8 and 0.7 mm for the rectangular type. The
average length of the elongated type was 4.4 mm.
The average distances of the midpoint of the sacrococ-
cygeal joint and the tip of the coccyx to the ganglion
impar were 8.6 mm (0–19.3 mm) and 25.0 mm (10.7–
37.4 mm), respectively. The relative index of the loca-
tion of the ganglion impar was calculated from the de-
termined distances, as described in the Materials and
Methods. Its value varied from 0 to 0.6, with a median
and average value of 0.3 (fig. 1). The frequency accord-
ing to the distance of the ganglion impar from the tip of
the coccyx was also calculated (fig. 2). The size of the
coccyx ranged from 18.2 to 48.1 mm, with a mean of
33.3 mm. The relation between the size of the coccyx
and the distance of the ganglion impar from the coccy-
geal tip was statistically significant (P  0.001) (fig. 3).
The branch from the ventral ramus of the sacral nerve
was observed to run close to the ganglion impar in one
(4%) or both sides (2%). The shortest distance between
the nerve branch and the ganglion impar ranged from
2.8 to 10.3 mm, with a mean of 6.3 mm. One or two
coccygeal ganglia were observed in 12% of the samples.
Discussion
Since the blockade of the ganglion impar was first
introduced for the management of intractable perineal
pain in 1990 by Plancarte et al., a number of modified
methods have been reported, including the transsacro-
coccygeal ligament placement of a needle,1 the applica-
tion of a curved needle,2 and cryoablation through the
sacrococcygeal disc.4 However, the nature of the peri-
neal pain that can be relieved by the ganglion blockade
is neuropathic; hence, the perineal pain due to the
somatic invasion of malignancies is not the appropriate
indication for the blockade of the ganglion impar. Gan-
glion blockade was also reported to be effective in the
treatment of hyperhidrosis in the perineum and but-
tock.10,11 Although successful blockade of the ganglion
impar depends on accurately locating the ganglion,4 its
location has been described inconsistently. Previous re-
ports on the blockade of the ganglion depicted its loca-
tion anterior to the sacrococcygeal joint,1–4 but anatomy
textbooks locate it anterior to the coccyx5–8 or at the tip
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of the coccyx.9 The current study makes plain the wide
range of sizes of the coccyx and distances of the gan-
glion impar from the coccygeal tip, and the significant
correlation between them. The diverse locations of the
ganglion impar were represented by a relative index, and
the value of this index varied from 0 (locating it at the
sacrococcygeal joint) to 0.6 (below the midpoint of the
line joining the midpoint of sacrococcygeal joint and the
tip of the coccyx). The median and average index value
was 0.3, which was the midpoint between the two sites
with relative indexes of 0 and 0.6. This result implies
that the needle for the blockade of the ganglion impar
should be directed toward the site with an index value of
0.3 rather than at the sacrococcygeal junction, the con-
ventional injection site in previous reports.1–4
The branches from the ventral ramus of the sacral
nerve were observed to run close to the ganglion impar
in 3 of the 50 samples. Considering the risks of the
development of neuritis and neuralgia after chemical
neurolysis,12 this finding suggests that the amount of
blocking agents should be minimized to avoid possible
injury of the sacral nerve branch. However, the determi-
nation of the minimal and optimal amounts of blocking
agents requires further clinical investigation.
The authors thank Dong-Su Jang, B.A. (Research Assistant, Department of
Anatomy, Yonsei University College of Medicine, Seoul, Korea), for his help with
the figures.
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Fig. 1. The locations of the ganglion impar, in terms of relative
index.
Fig. 2. Frequency of the distance of the ganglion impar (GI)
from the tip of the coccyx.
Fig. 3. Correlation between the size of the coccyx and the dis-
tance of the ganglion impar (GI) from the tip of the coccyx.
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Effects of Bupivacaine Enantiomers and Ropivacaine
on Vasorelaxation Mediated by Adenosine
Triphosphate–sensitive K Channels in the Rat Aorta
Mayuko Dojo, M.D.,* Hiroyuki Kinoshita, M.D., Ph.D.,† Katsutoshi Nakahata, M.D.,‡ Yoshiki Kimoto, M.D.,§
Yoshio Hatano, M.D., Ph.D.
THE actions of local anesthetics on the nervous system
are reportedly related to their effects on K as well as Na
channels in neurons.1 Importantly, among these K chan-
nels in the nervous system, a voltage-insensitive flickering
K channels has been found to be more sensitive than the
Na channel to lipophilic, amide-linked local anesthetics,
especially to the piperidine derivatives bupivacaine and
ropivacaine.2,3 The flickering K channel was mostly
found in thin, myelinated nerve fibers, and it is a possible
candidate for generating the resting potential of these fi-
bers.4 Therefore, these results indicate that the inhibition
of K channels contributes to the action of bupivacaine
and ropivacaine on the nervous system.
Cumulative findings have demonstrated that K chan-
nels play crucial roles in physiologic and pathophysio-
logic vasodilation.5–7 Although S()-bupivacaine is less
toxic on cardiac function or the central nervous system
than racemic bupivacaine,8,9 the effects of bupivacaine
enantiomers on K channels of vascular smooth muscle
have not been studied. In addition, whether the S()-
enantiomer ropivacaine affects these channels of vascu-
lar smooth muscle has been unknown.
Therefore, the current study was designed to deter-
mine the potency of amide-linked long-acting local anes-
thetic drugs on K channels of vascular smooth muscle,
by examining whether bupivacaine enantiomers as well
as ropivacaine modify vasorelaxation induced by an
adenosine triphosphate (ATP)–sensitive K channel
opener in the isolated rat aorta.
Materials and Methods
The institutional animal care and use committee
(Wakayama, Japan) approved this study. Male Wistar rats
(weight, 250–350 g) were anesthetized with inhalation
of 3% halothane. Under this anesthetic condition,
the rats were killed by exsanguination, and thoracic
aortas were harvested. Thoracic aortic rings of 2.5 mm
in length were studied in modified Krebs-Ringer’s bicar-
bonate solution (control solution) of the following com-
position: 119 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2,
1.17 mM MgSO4, 1.18 mM KH2PO4, 25 mM NaHCO3, and
11 mM glucose. In some rings, the endothelium was
removed mechanically, and the endothelial removal
or preservation was confirmed by the absence or the
presence of the relaxation in response to acetylcholine
(105 M), respectively. Several rings cut from the same
artery were studied in parallel. Each ring was connected
to an isometric force transducer and suspended in an or-
gan chamber filled with 10 ml control solution (37°C, pH
7.4) bubbled with 95% O2 and 5% CO2. The artery was
gradually stretched to the optimal point of its length–
tension curve as determined by the contraction to phen-
ylephrine (3  107 M). In most of the studied arteries,
optimal tension was achieved at approximately 1.5 g.
During submaximal contraction to phenylephrine, the
concentration–response curve to levcromakalim or dilti-
azem was obtained. Some rings were treated with glib-
enclamide, S()- or R()-bupivacaine, or ropivacaine,
which was given 15 min before addition of phenyleph-
rine (3  107 M). The vasorelaxation was expressed as
a percentage of the maximal relaxation in response to
papaverine (3  104 M), which was added at the end of
experiments to produce the maximal relaxation (100%)
of arteries.
Drugs
The following pharmacologic agents were used: dilti-
azem, dimethyl sulfoxide, glibenclamide, and phenyl-
ephrine (Sigma, St. Louis, MO). Levcromakalim and S()-
bupivacaine, R()-bupivacaine, and ropivacaine were
gifts from GlaxoSmithKline plc (Greenford, United King-
dom) or AstraZeneca Pharmaceutical Co. (Södertälje,
Sweden), respectively. Drugs, except for levcromakalim
and glibenclamide, were dissolved in distilled water such
that volumes of less than 60 l were added to the organ
chambers. Stock solutions of levcromakalim (105 M)
and glibenclamide (105 M) were prepared in dimethyl
sulfoxide (3  104 M).
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Statistical Analysis
Data are expressed as mean  SD. Statistical analysis
was performed using repeated-measures analysis of vari-
ance, followed by the Scheffé F test for multiple com-
parisons. Differences were considered to be statistically
significant when P was less than 0.05.
Results
During submaximal contraction to phenylephrine (3
107 M), the selective ATP-sensitive K channel opener
levcromakalim (108 to 105 M) produced vasorelax-
ation of the rat aorta with or without endothelium in a
concentration-dependent fashion (fig. 1). This relaxation
was abolished by a selective ATP-sensitive K channel
antagonist glibenclamide (105 M) (fig. 1). In the aortas
with endothelium, R()-bupivacaine (106 to 105 M)
and S()-bupivacaine (3  106 to 105 M) inhibited
vasorelaxation in response to levcromakalim in a con-
centration-dependent fashion, whereas ropivacaine did
not affect this vasorelaxation (fig. 2A). In the aortas
without endothelium, R()-bupivacaine (3  106 to
105 M) inhibited vasorelaxation to levcromakalim in a
concentration-dependent fashion, whereas S()-bupiva-
caine reduced the relaxation only in the highest concen-
tration used, and ropivacaine did not alter this vasore-
laxation (fig. 2B).
The highest concentration of each compound (105 M)
did not affect vasorelaxation in response to the voltage-
dependent Ca2 channel antagonist diltiazem (108 to
3  104 M) (fig. 3).
Discussion
Levcromakalim is a selective ATP-sensitive K channel
opener in the rat aorta, suggesting that this preparation
is a suitable model by which we can evaluate the role of
ATP-sensitive K channels in vascular smooth muscle.7
In the rat aortas with and without endothelium, R()-
bupivacaine caused the rather augmented inhibitory ef-
fect on the vasorelaxation via ATP-sensitive K chan-
nels, compared with S()-isomer, although both R()-
and S()-bupivacaine inhibited the vasorelaxation in a
concentration-dependent fashion. These results support
the following conclusions. First, the effects of bupiva-
caine enantiomers on vasorelaxation via ATP-sensitive
K channels are mostly mediated by their effects on
these channels on vascular smooth muscle cells, because
inhibitory actions of bupivacaine enantiomers were sim-
ilar between the aortas with and without endothelium.
Second, bupivacaine seems to stereoselectively reduce
the vasorelaxation mediated by ATP-sensitive K chan-
nels. Previous studies on rat cardiac myocytes, bovine
adrenal zona fasciculata cells, and native Xenopus oo-
cytes demonstrated that racemic bupivacaine, contain-
ing R()- and S()-bupivacaine, reduces ATP-sensitive
K currents.10–12 These results obtained from studies
performed using tissues other than blood vessels are
certainly in agreement with our findings that bupiva-
caine enantiomers reduced vasorelaxation mediated by
ATP-sensitive K channels. In the rat aorta, the pure
S()-enantiomer ropivacaine did not alter vasorelaxation
caused by an ATP-sensitive K channel opener. Consid-
ering the above findings regarding the inhibitory effects
of bupivacaine enantiomers, it is likely that S()-enanti-
omers of local anesthetics show less potent effects on
vasorelaxation mediated by ATP-sensitive K channels.
In addition, ropivacaine, compared with S()-bupiva-
caine, seems to have less impact on these K channels of
vascular smooth muscle cells.
The ATP-sensitive K channel is a complex of two
proteins: the sulfonylurea receptor and Kir6.1 or 6.2,
which belongs to the inward rectifier K channel fami-
ly.13 Because the sulfonylurea receptor of ATP-sensitive
K channel is reportedly a primary target of the openers
of this channel, it is most likely that bupivacaine enanti-
Fig. 1. Concentration–response curves to
levcromakalim (108 to 105 M) in the
absence and in the presence of gliben-
clamide (105 M), obtained in the rat tho-
racic aorta with or without endothelium.
Data are shown as mean  SD and ex-
pressed as percent of maximal vasorelax-
ation induced by papaverine (3  104
M). * Difference between control rings
and rings treated with glibenclamide is
statistically significant (P < 0.05).
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omers modify vasorelaxation in response to an ATP-
sensitive K channel opener via the effect on the sulfo-
nylurea receptor of these channels.14 However, a recent
study has found that racemic bupivacaine inhibits G
protein–gated inward rectifier K channels by antago-
nizing the interaction of phosphatidylinositol 4,5-
bisphosphate with the channel.15 Therefore, we cannot
rule out the possibility that bupivacaine may act on the
compartment of inward rectifier K channel family in
ATP-sensitive K channels. In any case, it is highly pos-
sible that bupivacaine, which is a lipophilic anesthetic,
directly affects some channel compartments because
recent studies have already reported such direct action
of bupivacaine on voltage-dependent K channel
proteins.16,17
Each compound evaluated in the current study, even
in the highest concentration used, did not affect vasore-
laxation in response to a voltage-dependent Ca2 chan-
nel antagonist diltiazem. These results may support the
concept that bupivacaine does not inhibit vasodilator
responses in general. Our findings that neither bupiva-
caine enantiomers nor ropivacaine affect contraction in
response to phenylephrine and maximal relaxation in-
duced by papaverine (data not shown) also neglect the
possibility that the inhibitory effect of bupivacaine on
vasorelaxation mediated by ATP-sensitive K channels is
due to its vasoconstrictor effect on the aorta.
Thresholds of a free plasma concentration in humans
for central nervous toxicity were reported up to 1.5 
106 M and 2.6  106 M for racemic bupivacaine and
ropivacaine, respectively.18 A recent study has found
that free plasma concentrations higher than 1.5 
106 M are seen in infants during epidural infusion of
bupivacaine because of a low -1 acid glycoprotein con-
centration.19 Therefore, our results suggest that in clin-
ical situations, bupivacaine enantiomers, especially
R()-bupivacaine, impair vasodilation mediated by ATP-
sensitive K channels, whereas ropivacaine does not
alter the vasodilation.
During hypoxia, acidosis, and ischemia, ATP-sensitive
K channels are activated, resulting in arterial dilation or
increased tolerance of tissues to ischemia or both.6,20,21
Although it is still unclear whether our results have
relevance to vasodilation in resistance blood vessels,
during pathophysiologic situations, bupivacaine enanti-
omers, especially R()-bupivacaine, but not ropiva-
Fig. 2. (A) Concentration–response
curves to levcromakalim in the absence
or in the presence of R()-bupivacaine,
S()-bupivacaine, or ropivacaine (106, 3
 106, 105 M), obtained in the rat tho-
racic aorta with endothelium. Data are
shown as mean  SD and expressed as
percent of maximal vasorelaxation in-
duced by papaverine (3  104 M). * Dif-
ference between control rings and rings
treated with R()-bupivacaine (106, 3 
106, 105 M) or S()-bupivacaine (3 
106, 105 M) is statistically significant (P
< 0.05). (B) Concentration–response
curves to levcromakalim in the absence
or in the presence of R()-bupivacaine,
S()-bupivacaine, or ropivacaine (106, 3
 106, 105 M), obtained in the rat tho-
racic aorta without endothelium. Data
are shown as mean  SD and expressed
as percent of maximal vasorelaxation in-
duced by papaverine (3  104 M). * Dif-
ference between control rings and rings
treated with R()-bupivacaine or S()-
bupivacaine is statistically significant
(P < 0.05).
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caine, may impair vasodilator effects induced by activa-
tion of ATP-sensitive K channels, which play an
important role in regulation of circulation.
In conclusion, this is the first study evaluating the
effects of amide-linked long-acting local anesthetics, in-
cluding bupivacaine enantiomers and ropivacaine, on
K channels of vascular smooth muscle. From our re-
sults, S()-enantiomers of amide-linked local anesthetics
seem to show less potent effects on vasorelaxation me-
diated by ATP-sensitive K channels. In these S()-iso-
mers, ropivacaine may not affect these K channels of
vascular smooth muscle cells.
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